BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18220289)

  • 1. Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
    Streetz KL; Doyonnas R; Grimm D; Jenkins DD; Fuess S; Perryman S; Lin J; Trautwein C; Shizuru J; Blau H; Sylvester KG; Kay MA
    Hepatology; 2008 Feb; 47(2):706-18. PubMed ID: 18220289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice.
    Tschaharganeh DF; Kaldenbach M; Erschfeld S; Tischendorf JJ; Trautwein C; Streetz KL
    Liver Transpl; 2010 Jan; 16(1):23-32. PubMed ID: 20035522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic injury and the kinetics of bone marrow-derived hepatocyte transgene expression.
    Perryman SV; Jenkins DD; Streetz KL; Longaker MT; Sylvester KG
    J Pediatr Surg; 2008 Aug; 43(8):1511-9. PubMed ID: 18675644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived, liver-specific protein expression after bone marrow transplantation.
    Jenkins DD; Streetz K; Tataria M; Sahar D; Kurobe M; Longaker MT; Kay MA; Sylvester KG
    Transplantation; 2004 Aug; 78(4):530-6. PubMed ID: 15446311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice.
    Eggenhofer E; Popp FC; Renner P; Slowik P; Neuwinger A; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2008 Nov; 36(11):1507-13. PubMed ID: 18715687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
    Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
    Bumgardner GL; Orosz CG
    Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The distribution of donor hematopoietic stem cell and the ratio of lymphocytes from donor origin to recipient origin in recipient mice after allogeneic bone marrow transplantation].
    Shen SJ; Li XY; Wang LP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):393-6. PubMed ID: 16251017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation.
    Hu B; Bao G; Zhang Y; Lin D; Wu Y; Wu D; Liu H
    J Immunol; 2012 Aug; 189(4):1661-70. PubMed ID: 22798668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.